INTRODUCTION {#s1}
============

Acinetobacter species are important pathogens frequently responsible for causing nosocomial infections, mainly in patients hospitalized at intensive care units (ICU) ([@B1], [@B2]). The spread of major carbapenem-resistant A. baumannii clones has been associated with the increasing frequency of the carbapenem resistance phenotype worldwide ([@B1]). The production of [c]{.ul}arbapenem-[h]{.ul}ydrolyzing [c]{.ul}lass D β-[l]{.ul}actamases (CHDLs) has been reported to be the main mechanism of carbapenem resistance ([@B3]). The spread of multidrug-resistant (MDR) A. baumannii sequence type 79 (ST79) isolates carrying *bla*~OXA-23~ and, more recently, *bla*~OXA-72~ has contributed to the high carbapenem resistance rates (85%) observed in Brazil ([@B3]). In contrast, *bla*~OXA-58~ has been rarely reported in this country, contrasting with the high frequency of this CHDL-encoding gene seen in neighboring countries, mainly in Argentina ([@B4]). To date, only six OXA-58-producing Acinetobacter species strains recovered from human ([@B5][@B6][@B8]) and environmental ([@B9]) sources have been reported in distinct Brazilian cities since the 90s ([@B5][@B6][@B9]). The diverse genetic structures surrounding *bla*~OXA-58~ documented worldwide ([@B3], [@B10], [@B11]) play a major role not only in the mobilization of this resistance determinant but also in driving its expression, decisively leading to the carbapenem resistance phenotype ([@B3], [@B12]).

The carriage of *bla*~OXA-58~ by distinct Acinetobacter species recovered over a long period of time---3 decades---suggests that this CHDL-encoding gene has been mobilized by horizontal gene transfer (HGT), although the hypothesis of clonal spread could not be completely discarded. In order to reveal the genetic environment of *bla*~OXA-58~ and the corresponding implications for the mobilization and maintenance of this resistance determinant over time, we molecularly characterize two distinct plasmids harboring *bla*~OXA-58~ obtained from A. seifertii and A. baumannii clinical strains recovered in the years 1993 and 2010, respectively, from distinct Brazilian geographic regions.

RESULTS {#s2}
=======

Two distinct plasmids were obtained for each strain according to WPS analysis, and the plasmids were named pAs1069_a (24,672 bp/44 open reading frames \[ORFs\]) and pAs1069_b (13,129 bp/14 ORFs) for the A. seifertii Asp-1069 strain that belongs to ST551^IP^ (Institut Pasteur scheme). For A. baumannii Acb-45063 strain ST15/CC15^IP^, two plasmids were also detected and were named pAb45063_a (183,767 bp/209 ORFs) and pAb45063_b (19,808 bp/24 ORFs) ([Table 1](#tab1){ref-type="table"}). Plasmids of similar sizes were observed by alkaline lysis gel analysis (data not shown), considering an accepted variation range of ±10%, as follows: ∼155-kb and ∼32-kb plasmids for strain Acb-45063, corresponding to pAb45063_a and pAb45063_b, respectively, and ∼32-kb and ∼21-kb plasmids for strain Asp-1069, corresponding to pAs1069_a and pAs1069_b, respectively. WPS analysis demonstrated that *bla*~OXA-58~ genes were carried by pAs1069_a/24,672-bp ([Fig. 1A](#fig1){ref-type="fig"}) and pAb45063_b/19,808-bp ([Fig. 1B](#fig1){ref-type="fig"}) plasmids, which belong to the A. baumannii replicon type group (AbGR) GR8/GR23 (*repAci23*) and GR4 (*repAci4*), respectively ([Table 1](#tab1){ref-type="table"}). On pAb45063_b, *bla*~OXA-58~ was flanked by two intact copies of IS*Aba3* ([Fig. 2A](#fig2){ref-type="fig"}). In contrast, the genetic environment surrounding *bla*~OXA-58~ on pAs1069_a revealed an imperfect 5′ IS*Aba3* that was disrupted by an IS*Aba825* and an intact copy of IS*Aba3* downstream ([Fig. 2B](#fig2){ref-type="fig"}). Putative promoter regions of *bla*~OXA-58~ were predicted for pAb45063_b and for pAs1069_a, conferred by IS*Aba3* and by IS*Aba825*, respectively ([Fig. 2A](#fig2){ref-type="fig"} and [B](#fig2){ref-type="fig"}). IS*Aba825* generates a 4-bp duplication (AACT) upon transposition ([Fig. 2B](#fig2){ref-type="fig"}).

###### 

Microbiological data and plasmid characterization of two OXA-58-producing Acinetobacter species clinical isolates recovered in Brazil[^*a*^](#ngtab1.1){ref-type="table-fn"}

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Strain       Species        Yr of\      Clinical\           MLST    MIC (μg/ml)                                    Plasmid         Size\   ORF   G+C\   AbGR   Genetic marker(s)                                                                                                       
                              Isolation   specimen                                                                                   (bp)          (%)                                                                                                                                   
  ------------ -------------- ----------- ------------------- ------- ---------------------------------------------- --------------- ------- ----- ------ ------ ------------------- ---- ----- ------ ------ ------ ------------ --------- ----- ------- ----- ------------------------ ----------------
  Asp-1069     A. seifertii   1993        Tracheal aspirate   ST551   256                                            128             128     32    32     256    512                 1    0.5   0.25   4      \>32   pAs1069_a    24,672    44    36.62   GR8   *aphA6*, *bla*~OXA-58~   *map*

  pAs1069_b    13,129         14          35.65               NT                                                     *ppa*                                                                                                                                                               

                                                                                                                                                                                                                                                                                         

  Acb-45063    A. baumannii   2010        Blood               ST15    256                                            512             64      32    16     8      512                 64   1     0.25   0.06   \>32   pAb45063_a   183,767   209   37.61   NT    *strA*, *strB*, *sul2*   *sulP*, *glmM*

  pAb45063_b   19,808         24          38.51               GR4     *aac(*3*)-IIa*, *bla*~TEM-1B~, *bla*~OXA-58~   *tonB*, *sep*                                                                                                                                                       
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

![](mSphere.00376-19-t0001)

MLST, multilocus sequence typing; CAZ, ceftazidime; CRO, ceftriaxone; FEP, cefepime; IPM, imipenem; MEM, meropenem; AMK, amikacin; GEN, gentamicin; CIP, ciprofloxacin; TIG, tigecycline; MIN, minocycline; PMB, polymyxin B; SUT, trimethoprim-sulfamethoxazole; ORF, open reading frame; G+C, guanine-cytosine content; AbGR, Acinetobacter replicon type group; NT, nontypeable.

![Schematic representation of circular plasmid maps found in A. seifertii Asp-1069 (A and C) and A. baumannii Acb-45063 (B and D) strains. Arrows designate transcription directions of genes and ORFs. Genes were grouped according to their predictive functions as indicated by the color coding key.](mSphere.00376-19-f0001){#fig1}

![Genetic contexts surrounding *bla*~OXA-58~ found in plasmids pAb45063_b (A) and pAs1069_a (B). Genes and their transcriptional orientations are represented by horizontal arrows. Identical genes found in both genetic structures are represented with the same colors. Genes of no predicted functions (HP \[hypothetical proteins\]) are represented in white. The putative original promoters driving the expression of *bla*~OXA-58~ genes are highlighted. Direct repeat sequences are represented by an asterisk (\*). Gene names preceded by an uppercase Greek delta (Δ) represent truncated genes, and the corresponding regions are shaded in gray. The Re27 regions are boxed. Promoter prediction for *bla*~OXA-58~ was performed using BPROM (SoftBerry).](mSphere.00376-19-f0002){#fig2}

Two Re27 sequences were found adjacent to an IS*Aba3-bla*~OXA-58~-IS*Aba3* arrangement on pAb45063_b, with Re27-1 located upstream of 5′-IS*Aba3* and Re27-2 adjacent to IS*Aba125* located downstream of *araC1* and *lysE* genes ([Fig. 2A](#fig2){ref-type="fig"}), which coded for a threonine efflux protein and a transcriptional regulator, respectively. In contrast, we failed to identify Re27-like regions on pAs1069_a. In this plasmid, *lysE* was disrupted by Tn*aphA6*, which harbored aminoglycoside modifying enzyme (AME)-encoding gene *aphA6*. This AME confers resistance to gentamicin and amikacin. *aphA6* was flanked by two copies of IS*Aba125* in the same orientation ([Fig. 2B](#fig2){ref-type="fig"}), while Tn*aphA6* generates a 7-bp duplication (ATTCGCC) upon transposition ([Fig. 2B](#fig2){ref-type="fig"}). The production of aminoglycoside O-phosphotransferase AphA6 by A. seifertii Asp-1069 justified the high MICs for amikacin (256 μg/ml) and gentamicin (512 μg/ml) verified in such strain ([Table 1](#tab1){ref-type="table"}). In addition, a genetic arrangement composed of two copies of IS*26* and the narrow-spectrum-β-lactamase-encoding gene *bla*~TEM-1~ and the AME-encoding gene *aac(*3*)-IIa* was also found upstream of IS*Aba3-bla*~OXA-58~-IS*Aba3* on pAb45063_b ([Fig. 2A](#fig2){ref-type="fig"}). AAC(3)-IIa confers a high level of resistance to gentamicin but not amikacin, justifying the phenotype observed for A. baumannii Acb-45063 (MICs of 512 and 8 μg/ml for gentamicin and amikacin, respectively; [Table 1](#tab1){ref-type="table"}). Other two plasmids (pAb45063_a and pAs1069_b) were also detected in the OXA-58-producing Acinetobacter species strains evaluated in the present study ([Fig. 1C](#fig1){ref-type="fig"} and [D](#fig1){ref-type="fig"}). The 183,767-bp plasmid Ab45063_a carried the streptomycin resistance genes *strA* and *strB* and the sulfonamide resistance gene *sul2* ([Fig. 1D](#fig1){ref-type="fig"}), contrasting with the small plasmid pAs1069_b of 13,129 bp ([Fig. 1C](#fig1){ref-type="fig"}). Although the two OXA-58-producing Acinetobacter species strains showed similar profiles of susceptibility to β-lactams, A. baumannii Acb-45063 MICs were 0.06 μg/ml and 64 μg/ml for polymyxin B and ciprofloxacin, respectively, contrasting with those presented by A. seifertii Asp-1069 strains (MICs of 4 and 1 μg/ml for polymyxin B and ciprofloxacin, respectively) ([Table 1](#tab1){ref-type="table"}).

Distinct virulence factors were observed in all four plasmids ([Table 1](#tab1){ref-type="table"}) as follows: outer membrane protein-encoding gene *tonB*, septicolysin-encoding gene *spl*, phosphoglucosamine mutase-encoding gene *glmM*, inorganic pyrophosphatase-encoding gene *ppa*, sulfate permease-encoding gene *sulP*, and methionine aminopeptidase type I-encoding gene *map*. In addition, distinct toxin-antitoxin system-encoding genes were also detected in the two *bla*~OXA-58~-harboring plasmids ([Fig. 1A](#fig1){ref-type="fig"} and [B](#fig1){ref-type="fig"}), such as *stbD* and *relE* (pAs1069_a) and *brnT* and *brnA* (pAb45063_b). Although *xreE* was found in the large (183-kb) pAb45063_a plasmid ([Fig. 1D](#fig1){ref-type="fig"}), no toxin-antitoxin systems were found in the 13-kb pAs1069_b plasmid ([Fig. 1C](#fig1){ref-type="fig"}).

DISCUSSION {#s3}
==========

The plasmid carrying *bla*~OXA-58~, pAs1069_a, recovered from A. seifertii, shares 99% identity with the plasmid harboring *bla*~OXA-58~ pAb242_25 described in a MDR A. baumannii clinical strain (Ab242) isolated in the city of Rosario, Argentina ([@B4]). Interestingly, Ab242 strain was recovered in 1997 (11), 4 years later than the two clonally related OXA-58-producing A. seifertii clinical strains isolated in Brazil ([@B8]). Also, Narciso and colleagues described an OXA-58-producing A. seifertii strain (Ac-12.1) recovered in 2012 from a cloaca of a black-necked swan residing in the lakes of the São Paulo Zoo ([@B9]). This strain was clonally related to both A. seifertii clinical strains---including the Asp-1069 evaluated in the present study---isolated 19 years earlier in a tertiary hospital located in the city of São Paulo ([@B8], [@B9]). Since the genetic environment surrounding *bla*~OXA-58~ of Ac-12.1 was identical to that of the corresponding gene in the Asp-1069 strain, except for a truncated copy of 3′-IS*Aba3* (8, 9), it reinforces the idea of the capability of rearrangement and the complexity of transposable elements among plasmid-borne *bla*~OXA-58~ genes ([@B3]).

Although the OXA-58-producing A. baumannii Acb-45063 strain was included in ST15^IP^, it belongs to same clonal complex (CC15^IP^/CC103^OX^ \[Oxford scheme\]) as the Ab242 ST104^OX^ A. baumannii strain recovered in Argentina ([@B4]). Note that the city of Porto Alegre, where the Acb-45063 strain was recovered, is located in a Brazilian state next to the Argentinian border, where *bla*~OXA-58~ is prevalent and of public health concern ([@B4], [@B10]). However, the plasmids carrying *bla*~OXA-58~ detected in Argentinean and Brazilian A. baumannii strains showed distinct genetic backbones. Although plasmids carrying *bla*~OXA-58~ that belonged to GR8/GR23 were found among distinct Acinetobacter species in South American countries in the 1990s, a distinct genetic backbone surrounding *bla*~OXA-58~ was found in a GR4 plasmid from a A. baumannii Acb-45063 strain recovered in Brazil at 2010. According to Ravasi and colleagues, the presence of IS*Aba825* upstream of *bla*~OXA-58~, as observed in pAb45063_b (ΔIS*Aba3*/IS*Aba825-bla*~OXA-58~-IS*Aba3*), results in a hybrid promoter that overexpresses this CHDL, leading to 16-fold and 8-fold increases in the MICs for imipenem and meropenem, respectively ([@B13]). Re27-like sites found in pAb45063_b, but not in pAs1069_a, are short genomic sequences implicated in site specific recombination processes involved in the evolution of plasmids, many of them carrying CHDL-encoding genes ([@B4], [@B10], [@B14], [@B15]). These sequences have been identified bordering IS*Aba3*-like elements, allowing the occurrence of multiple recombination processes that promote different arrangements and acquisition of *bla*~OXA-58~ by Acinetobacter species ([@B4], [@B10][@B11][@B12], [@B14], [@B15]).

Although it has been previously suggested that the presence of virulence-encoding genes does not guarantee the expression of virulence factors and/or bacterial pathogenicity ([@B16]), curiously, our study revealed the presence of distinct virulence factors in all plasmids evaluated, some of which had never been described before in Acinetobacter spp. ([@B13], [@B15][@B16][@B17]). The TonB outer membrane protein is associated with iron uptake, and its expression may be related to the survival of the bacterial cell in the lungs and blood ([@B13], [@B16], [@B17]). The *spl* gene encodes a septicolysin with cytolytic activity related to the invasion of tissues or cells, while *glmM* codes for a phosphoglucosamine mutase that has been related as a highly sensitive predictor of several clinical outcomes ([@B13], [@B16], [@B17]). Other three genes found, *ppa*, *sulP*, and *map*, have been associated with bacterial pathogenicity ([@B4]). In addition, distinct toxin-antitoxin system-encoding genes found in three of four plasmids evaluated ensure the stability of transferable genetic elements in the bacterial host cell ([@B4], [@B15], [@B16]).

In conclusion, a complex and dynamic backbones were found surrounding the *bla*~OXA-58~ carried by distinct plasmids from A. seifertii and A. baumannii strains recovered 17 years apart in Brazil. Such data demonstrated that although this CHDL-encoding gene has rarely been reported in Brazil, genetic plasticity has occurred over time, composed of a variety of resistance and virulence markers associated with the stability conferred by toxin-antitoxin systems. These findings accounted in part for the success of efforts that have kept plasmids carrying *bla*~OXA-58~ from escaping nosocomial settings for a long period of time.

MATERIALS AND METHODS {#s4}
=====================

Ethical approval. {#s4.1}
-----------------

Ethical approval for this study was obtained from Research Ethics Committee from Federal University of São Paulo---UNIFESP/São Paulo Hospital (process number 5158010817).

Bacterial isolates. {#s4.2}
-------------------

Two OXA-58-producing Acinetobacter species clinical strains, Asp-1069 and Acb-45063, were selected for this study. The A. seifertii Asp-1069 strain was previously characterized ([@B8]) and is considered to be the most ancient Acinetobacter species carrying *bla*~OXA-58~ reported worldwide to date. Asp-1069 was recovered in 1993 from a tracheal aspirate of a patient hospitalized in the city of São Paulo, southeastern Brazilian region ([@B8]). The Acb-45063 strain was isolated in 2010 from a blood culture drawn from a patient hospitalized in the city of Porto Alegre, southern Brazilian region. For this study, the Acb-45063 strain was identified at the species level as A. baumannii by sequencing of partial regions of the RNA polymerase β subunit (*rpoB*) gene ([@B18]). The CHDL-encoding genes were confirmed by PCR followed by DNA sequencing using specific primers ([@B2], [@B8], [@B9]). MICs of 12 antimicrobial agents (Sigma-Aldrich, St. Louis, USA) were determined by cation-adjusted broth microdilution and interpreted according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines (<http://www.eucast.org/clinical_breakpoints>).

Multilocus sequence typing (MLST). {#s4.3}
----------------------------------

MLST analyses of Acb-45063 and Asp-1069 strains were performed by double-stranded DNA sequencing of internal regions of seven housekeeping genes (*cpn60*, *fusA*, *gltA*, *pyrG*, *recA*, *rplB*, and *rpoB*) following the Institute Pasteur scheme. Determination of the sequence type (ST) was performed through the A. baumannii MLST website (<http://pubmlst.org/abaumannii/>). The relationship between novel STs and existing STs was surveyed using the eBURST program (<http://eburst.mlst.net/>).

Plasmid DNA extraction using the alkaline lysis method. {#s4.4}
-------------------------------------------------------

For the calculation of the mean size of plasmids, the plasmid DNA extraction was performed by the alkaline lysis method according to the Birnboim and Doly protocol with a few modifications. One colony per bacterial isolate was inoculated into 3 ml of Trypticase soy broth (TSB) (Oxoid, Basingstoke, United Kingdom) in a tube and incubated at 37°C for 20 to 24 h. Aliquots of 1 ml each were subjected to centrifugation at 12,000 rpm for 3 min, and the pellet was resuspended in 100 μl of solution I (2 mg/ml lysozyme, 2% glucose, 10 mM EDTA, 25 mM Tris-HCl \[pH 8.0\], 1 mg/ml RNase). After 30 min of incubation in an ice bath, 200 μl of solution II (0.2 N NaOH and 1% SDS) was added. The supernatants were then homogenized by inversion and kept in an ice bath for 7 min. Then, 150 μl of solution III (3 M sodium acetate, pH 4.8) was added to the supernatants and homogenized by inversion and kept in an ice bath for 90 min for the sedimentation of chromosomal DNA. After that, the supernatants were centrifuged at 12,000 rpm for 10 min and transferred to new tubes, and 1 ml of ice-cold ethanol was added. The solution was homogenized by inversion to precipitate the plasmid DNA and incubated at --20°C overnight. The supernatants were centrifuged at 12,000 rpm for 10 min and resuspended in 100 μl of solution IV (100 mM sodium acetate, pH 8.0). Plasmid DNA was precipitated again by the addition of 200 μl of ice-cold ethanol and incubated at --20°C overnight. Finally, a new centrifugation was performed at 12,000 rpm for 10 min. The supernatants were discharged, and pellets were air dried and resuspended in 20 μl of sterile Mili-Q water. The plasmid DNA extractions were stored at --20°C. Electrophoresis was performed on 0.8% agarose (110 V/50 mA) for 2 h and stained with ethidium bromide. The calculation of the estimated plasmid sizes was based on a standard strain with known plasmid sizes running on the same agarose gel using a logarithmic curve.

Plasmid extraction and whole-plasmid sequencing (WPS). {#s4.5}
------------------------------------------------------

For WPS, the pool of plasmids was extracted using a QIAPrep Spin MiniPrep extraction kit (Qiagen, Hilden, Germany), concentrated in a Concentrator Plus evaporator (Eppendorf, Hamburg, Germany), and then quantified on a digital Nanovue Plus spectrophotometer (GE Healthcare, Canada). For library preparation, the extractions were quantified again in a Qubit 3.0 Fluorometer (Thermo Fisher Scientific, DE, USA). Libraries were constructed using an Illumina TruSeq Nano DNA LT library preparation kit---set A (Illumina, CA, USA) generating ∼550-bp fragments. WPS analysis was performed in a MiSeq platform (Illumina, CA, USA) (2 × 300 bp) in paired-end mode. The quality and quantification of the libraries were evaluated by quantitative real-time PCR (qRT-PCR).

Plasmid assembly, automatic annotation, and manual validation. {#s4.6}
--------------------------------------------------------------

First, plasmid reads were assembled using Newbler 3.0 (Kartchner, AZ, USA) and Ray 2.3.1 software (Université Laval, QC, Canada). The System for Automated Bacterial Integration of Annotation pipeline (SABIA; available in <http://www.sabia.lncc.br>) was used for gene prediction and automatic annotation with 90% coverage, 90% similarity, and an E value of \<10^−5^. For manual validation, the following platforms were used: NCBI BLAST, UniProt, ISFinder, ResFinder 2.1, Plasmid Finder 1.3, MLSTFinder, and VirulenceFinder 1.5. Creation of the illustration of the circularized plasmids and *in silico* analysis of A. baumannii replicon type group (AbGR) ([@B19]) were performed using Snap Gene software 3.3.3 (GSL Biotech LLC, Chicago, USA). BPROM (Softberry Inc, New York, USA) was applied for predicting promoter sequences. The genetic structures surrounding *bla*~OXA-58~ genes were analyzed according to a study previously published by Poirel and Nordmann ([@B20]).

Data accessibility. {#s4.7}
-------------------

The complete nucleotide sequences of pAs1069_a, pAs1069_b, pAb45063_a, and pAb45063_b have been submitted to GenBank under accession numbers [MK323040](https://www.ncbi.nlm.nih.gov/nuccore/MK323040), [MK323041](https://www.ncbi.nlm.nih.gov/nuccore/MK323041), [MK323042](https://www.ncbi.nlm.nih.gov/nuccore/MK323042), and [MK323043](https://www.ncbi.nlm.nih.gov/nuccore/MK323043), respectively.
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